Pharmacology | Comprehensive Lecture | MRCP(UK) Part 1 | Premium Lecture | Crack Medicine

Поділитися
Вставка
  • Опубліковано 22 гру 2024

КОМЕНТАРІ • 6

  • @portiaa1596
    @portiaa1596 5 місяців тому +1

    Very good video but the sound quality is not great

  • @mohammadnazmul539
    @mohammadnazmul539 Рік тому +1

    Thanks a lot sir

  • @maythanzinsoe8178
    @maythanzinsoe8178 Рік тому +1

    Thank you for free videos sir

  • @VipulSPanditg
    @VipulSPanditg Рік тому +1

    Andexanet alfa is the antodote of apixaban in Question 16 !

    • @CrackMedicine
      @CrackMedicine  Рік тому

      Thanks for the update Dr!
      As per the NICE guidelines, andexanet alfa for reversing anticoagulation (by apixaban or rivaroxaban) is recommended for routine use only in gastrointestinal bleeding. It is recommended only in research in ICH.
      While, Idarucizumab (Praxbind®) is the Licensed reversal agent for dabigatran.